Superworth

TriSalus Life Sciences EPS TLSI

Diluted earnings per share by quarter and over the last twelve months, from 2021.

Last 12 months, to Jun 30, 2026
−$1.30
Latest quarter, Q2 FY26
−$0.16
Fiscal year 2025
−$1.83

TriSalus Life Sciences' earnings per share was −$1.30 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.16.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$1.83n/a
FY2024−$1.33n/a
FY2023−$38.12n/a
FY2022−$25.80−14433%
FY2021$0.18n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.16n/a−$1.30
Q1 FY26$0.03n/a−$1.41
Q4 FY25−$0.21n/a−$1.83
Q3 FY25−$0.96n/a−$2.02
Q2 FY25−$0.27n/a−$1.18
Q1 FY25−$0.39n/a−$1.12
Q4 FY24−$0.40n/a−$1.33
Q3 FY24−$0.12n/a−$2.50
Q2 FY24−$0.21n/a−$2.52
Q1 FY24−$0.60n/a−$38.15
Q4 FY23−$1.57n/a−$38.12
Q3 FY23−$0.14n/a−$36.57

Against its peers

Companies in Medical - Instruments & Supplies nearest TriSalus Life Sciences' size, closest first, today.

CompanyEPS, 12 monthsGrowth
TLSITriSalus Life Sciences−$1.30
UTMDUtah Medical Products$3.28−12% a year
PDEXPro DEX$4.11+52% a year
INFUInfuSystem$0.41+78% a year
EMBCEmbecta$1.47+3% a year
KEQUKewaunee Scientific$2.76−33% a year
TCMDTactile Systems Technology$1.08+74% a year
MDXGMimedx$0.04−81% a year
MOVMovado$1.80+137% a year
APTAlpha Pro Tech$0.41+24% a year
IRMDIradimed$1.79+10% a year
Peer median$1.63

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on TriSalus Life Sciences

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.